EHR Inteligence - "Mount Sinai Links Genetics, EHRs For Personalized Medicine"

 – April 30, 2013  –– 

Personalized medicine is a cutting edge area of study that holds great promise for many, and The Mount Sinai Medical Center is at the forefront of the field, rapidly expanding their BioMe bank of patient DNA in order to conduct research and modify treatments to fit a patient's specific needs. "We know that genetically, some patients respond better to some drugs than others," explained Erwin Bottinger, MD, Principal Investigator of BioMe and Director of The Charles Bronfman Institute for Personalized Medicine where the BioMe information bank and CLIPMERGE platforms are housed.  "Our platforms are programmed to access that information to help physicians write informed prescriptions in the clinical setting." Learn more